ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-84.35M
↓ 19% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-71.10M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-84.35M | +31.1% |
| 2024 | $-122.36M | +7.0% |
| 2023 | $-131.64M | -45.2% |
| 2022 | $-90.65M | -24.1% |
| 2021 | $-73.02M | -90.6% |
| 2020 | $-38.32M | -162.4% |
| 2019 | $-14.60M | -5.5% |
| 2018 | $-13.84M | - |